CapsoVision Inc
CV
View Detailed Chart
4.960USD
+0.090+1.85%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
232.12MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.85%
5 Days
-1.20%
1 Month
-37.61%
6 Months
+17.54%
Year to Date
-53.60%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score of CapsoVision Inc
Currency: USD Updated: 2026-02-06Key Insights
CapsoVision Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 118 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.50.In the medium term, the stock price is expected to remain stable.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CapsoVision Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
CapsoVision Inc Highlights
StrengthsRisks
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.76M.
Overvalued
The company’s latest PE is -4.31, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 134.18K shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
10.500
Target Price
+115.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CapsoVision Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
CapsoVision Inc Info
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Ticker SymbolCV
CompanyCapsoVision Inc
CEOWang (Kang-Huai)
Websitehttps://www.capsovision.com/
Related Instruments
+2.98%
+0.07%
+1.60%
+2.48%
+0.31%
-1.14%
-0.05%
-2.35%
-1.78%
+2.65%
+2.59%
+2.03%
+2.01%
+2.38%
+1.74%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69635.340
-334.790 (-0.48%)
282.580
+22.390 (+8.61%)
2061.350
+9.620 (+0.47%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
